Perspective Therapeutics annual meeting results: all director nominees elected, say-on-pay approved

Perspective Therapeutics, Inc.

All five director nominees elected; Frank Morich received 35.4M for and 17.1M withheld (33% withhold).
Say-on-pay passed with 73.7% support (38.7M for, 13.7M against, 0.15M abstain), excluding 8.3M broker non-votes.
Ratification of WithumSmith+Brown as auditor approved with 59.1M for, 1.6M against, 0.14M abstain.
Quorum of 82.17% of 74,050,841 shares represented at the meeting.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.